JUBILANT PHARMACEUTICALS
0454.891.594 · rovalta.com · 25/09/2026
ACTIVE
JUBILANT PHARMACEUTICALS
Financial year 2025 · Closed on 31/03/2025
Net result-239,9 k €-32,9 %over 1 year
Revenue582,3 k €-38,9 %over 1 year
Equity-1 M €-29,7 %over 1 year
Overview
Identity
Source · BCE/KBOJUBILANT PHARMACEUTICALS is a Public limited company incorporated in 1995. Its main activity is: Legal activities. Its registered office is in Merelbeke-Melle.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0454.891.594
- Incorporation
- 14/04/1995
- Legal form
- Public limited company
- Registered office
- Guldensporenpark 22
9820 Merelbeke-Melle · FlandreSee on map - Contributed capital
- 1 050 300,00 €
- Latest accounts
- 31/03/2025
Joint committees (3)
- 100
- 218
- 219
Signals
Healthy social debts
Financials
Source · NBB, 19 filingsTrend over 19 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 582,3 k € | -38.9% | 953 k € | +40.2% | 679,8 k € | +10.9% | 612,8 k € | -34.1% | 930,5 k € |
| EBITDA | -207,2 k € | -15.3% | -179,7 k € | -25.7% | -142,9 k € | -102% | -70,8 k € | -1299% | 5,9 k € |
| Operating result | -207,2 k € | -15.3% | -179,7 k € | -25.7% | -142,9 k € | -102% | -70,8 k € | -1892% | 4 k € |
| Net result | -239,9 k € | -32.9% | -180,6 k € | -41.0% | -128,1 k € | -75.9% | -72,8 k € | -7994% | -899,4 € |
| Balance sheet | |||||||||
| Equity | -1 M € | -29.7% | -806,5 k € | -28.8% | -626 k € | -25.7% | -497,9 k € | -17.1% | -425,1 k € |
| Total assets | 335,9 k € | -31.2% | 488,1 k € | -26.5% | 663,8 k € | -9.1% | 730,7 k € | -12.5% | 835,4 k € |
| Cash | 27,4 k € | +27.3% | 21,5 k € | -84.2% | 136,2 k € | +914% | 13,4 k € | -92.9% | 188,2 k € |
| Debts | 1,4 M € | +6.8% | 1,3 M € | +0.4% | 1,3 M € | +5.0% | 1,2 M € | -2.5% | 1,3 M € |
| Other | |||||||||
| Workforce | – | – | – | – | – | ||||
Board of directors
Source · NBB, accounts to 31/03/20254 active · 47 ended
Active mandates
Guilliano Perfetti
ActiveMichael Van Ohlen
ActiveRajesh Bhatia
ActiveRajpal Dr. Jaidev Sanjeev
ActiveEnded mandates
Michael Von Ohlen
EndedRajapl Dr. Jaidev Sanjeev
EndedRajesh Bhatia
EndedRajpal Dr. Jaidev Sanjeev
EndedOther companies at this address
Guldensporenpark 22 9820 Merelbeke-Melle| Company | CBE no. |
|---|---|
JUBILANT LIFE SCIENCES● Active | 0536.745.342 |
JUBILANT PHARMA● Active | 0865.497.049 |
PSI SUPPLY● Active | 0480.185.731 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/04/2024 | 01/04/2023 | 01/04/2022 | 01/04/2021 | 01/04/2020 | 01/04/2019 |
| Closing of the financial year | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 | 31/03/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 06/10/2025 | 02/10/2024 | 31/10/2023 | 28/10/2022 | 29/10/2021 | 29/10/2020 |
| General meeting | 26/09/2025 | 30/09/2024 | 30/09/2023 | 27/09/2022 | 30/09/2021 | 30/09/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 19 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/03/2025 | 26/09/2025 | 06/10/2025 | Dutch | |
| Full model | 31/03/2024 | 30/09/2024 | 02/10/2024 | Dutch | |
| Full model | 31/03/2023 | 30/09/2023 | 31/10/2023 | Dutch | |
| Full model | 31/03/2022 | 27/09/2022 | 28/10/2022 | Dutch | |
| Full model | 31/03/2021 | 30/09/2021 | 29/10/2021 | Dutch | |
| Full model | 31/03/2020 | 30/09/2020 | 29/10/2020 | Dutch | |
| Full model | 31/03/2019 | 30/09/2019 | 30/10/2019 | Dutch | |
| Full model | 31/03/2018 | 30/09/2018 | 25/10/2018 | Dutch | |
| Full model | 31/03/2017 | 01/09/2017 | 26/10/2017 | Dutch | |
| Full model | 31/03/2016 | 01/09/2016 | 26/09/2016 | Dutch | |
| Full model | 31/03/2015 | 01/09/2015 | 29/09/2015 | Dutch | |
| Full model | 31/03/2014 | 01/09/2014 | 29/09/2014 | Dutch | |
| Full model | 31/03/2013 | 23/08/2013 | 19/09/2013 | Dutch | |
| Full model | 31/03/2012 | 22/09/2012 | 18/10/2012 | Dutch | |
| Full model | 31/03/2011 | 24/09/2011 | 10/10/2011 | Dutch | |
| Full model | 31/03/2010 | 25/09/2010 | 25/10/2010 | Dutch | |
| Full model | 31/03/2009 | 26/09/2009 | 22/10/2009 | Dutch | |
| Full model | 31/03/2008 | 27/09/2008 | 27/11/2008 | Dutch | |
| Full model | 31/03/2007 | 22/09/2007 | 13/12/2007 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/03/20254 active · 47 ended
Active mandates
Guilliano Perfetti
ActiveMichael Van Ohlen
ActiveRajesh Bhatia
ActiveRajpal Dr. Jaidev Sanjeev
ActiveEnded mandates
Michael Von Ohlen
EndedRajapl Dr. Jaidev Sanjeev
EndedRajesh Bhatia
EndedRajpal Dr. Jaidev Sanjeev
EndedOwnership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Other06/07/2026—
- Other19/09/2024STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Mandates01/02/2024ONTSLAGEN - BENOEMINGEN
- Mandates20/04/2023ONTSLAGEN - BENOEMINGEN
- Mandates09/03/2023ONTSLAGEN - BENOEMINGEN
- Mandates24/01/2023ONTSLAGEN - BENOEMINGEN
- Mandates27/09/2021ONTSLAGEN - BENOEMINGEN
- Mandates21/01/2021ONTSLAGEN - BENOEMINGEN
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-239,9 k €↓
- 2024Annual accounts 2024-180,6 k €↓
- 2023Annual accounts 2023-128,1 k €↓
- 2022Annual accounts 2022-72,8 k €↓
- 2021Annual accounts 2021-899,4 €↓
- 2020Annual accounts 20205,7 k €↓
- 2019Annual accounts 201931,6 k €↑
- 2018Annual accounts 2018-48,4 k €↓
- 2017Annual accounts 201765,2 k €↑
- 2016Annual accounts 2016-334,8 k €↑
- 2015Annual accounts 2015-384,1 k €↑
- 2014Annual accounts 2014-609,3 k €↓
- 2013Annual accounts 2013588,6 k €↑
- 2012Annual accounts 201219 k €↓
- 2011Annual accounts 201146,5 k €↑
- 2010Annual accounts 2010-329,6 k €↑
- 2009Annual accounts 2009-613,4 k €↑
- 2008Annual accounts 2008-1,1 M €↓
- 2007Annual accounts 2007-157,5 k €
- 14/04/1995IncorporationPublic limited company